Jefferies Downgrades Deciphera Pharmaceuticals to Hold, Lowers Price Target to $25.6

Deciphera Pharmaceuticals Delist Post

Deciphera Pharmaceuticals

DCPH

25.59

25.59

Delist

0.00% Post

Jefferies analyst Eun Yang downgrades Deciphera Pharmaceuticals (NASDAQ: DCPH) from Buy to Hold and lowers the price target from $26 to $25.6.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via